Dysregulated adaptive immune response contributes to severe COVID-19.,Cell Research

当前位置： X-MOL 学术 › Cell Res. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Dysregulated adaptive immune response contributes to severe COVID-19.
Cell Research ( IF 28.1 ) Pub Date : 2020-08-05 , DOI: 10.1038/s41422-020-0391-9
Kuai Yu ₁ , Jingjing He ₁ , Yongjian Wu ₂ , Baosong Xie ₃ , Xuefei Liu ₁ , Bo Wei _{4,

5} , Haibo Zhou ₆ , Bingliang Lin ₇ , Zhixiang Zuo ₁ , Wen Wen ₈ , Wenxiong Xu ₇ , Bin Zou ₉ , Lai Wei ₉ , Xi Huang ₂ , Penghui Zhou ₁

Affiliation

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
Center for Infection and Immunity, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, 519000, China.
Department of Pulmonary and Critical Care Medicine, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, Fujian, 350001, China.
Infectious Disease Department, The Second Affiliated Hospital of Naval Military Medical University, Shanghai, 200003, China.
Huoshenshan Hospital, Wuhan, Hubei, 430000, China.
The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, Guangdong, 511500, China.
Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, 510630, China.
Department of Respiratory and Critical Care Medicine, Fuzhou General Hospital of Fujian Medical University, Fuzhou, Fujian, 350025, China.
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, China.